These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
725 related articles for article (PubMed ID: 23615959)
1. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children. Khanna R; Jariwala K; Bentley JP Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959 [TBL] [Abstract][Full Text] [Related]
2. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran. Zare F; Ameri H; Madadizadeh F; Aghaei MR Diabetes Metab Syndr; 2021; 15(1):319-324. PubMed ID: 33486224 [TBL] [Abstract][Full Text] [Related]
3. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression. O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689 [TBL] [Abstract][Full Text] [Related]
4. What does Cronbach's alpha tell us about the EQ-5D? A methodological commentary to "Psychometric properties of the EuroQol Five-Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children". Konerding U Qual Life Res; 2013 Dec; 22(10):2939-40. PubMed ID: 23709048 [No Abstract] [Full Text] [Related]
5. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone. Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069 [TBL] [Abstract][Full Text] [Related]
6. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi. Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714 [TBL] [Abstract][Full Text] [Related]
7. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788 [TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Kim TH; Jo MW; Lee SI; Kim SH; Chung SM Qual Life Res; 2013 Oct; 22(8):2245-53. PubMed ID: 23224560 [TBL] [Abstract][Full Text] [Related]
9. Validation and reliability of the Chichewa translation of the EQ-5D quality of life questionnaire in adults with orthopaedic injuries in Malawi. Chokotho L; Mkandawire N; Conway D; Wu HH; Shearer DD; Hallan G; Gjertsen JE; Young S; Lau BC Malawi Med J; 2017 Jun; 29(2):84-88. PubMed ID: 28955412 [TBL] [Abstract][Full Text] [Related]
10. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population. Kangwanrattanakul K; Parmontree P Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315 [TBL] [Abstract][Full Text] [Related]
11. Validity of EQ-5D-5L in stroke. Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978 [TBL] [Abstract][Full Text] [Related]
12. Normative Values and Psychometric Properties of EQ-5D-Y-3L in Chilean Youth Population among Different Weight Statuses. Perez-Sousa MA; Olivares PR; Carrasco-Zahinos R; Garcia-Hermoso A Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901107 [TBL] [Abstract][Full Text] [Related]
13. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430 [TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness. Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346 [TBL] [Abstract][Full Text] [Related]
15. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA. Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients. Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China. Zhao L; Liu X; Liu D; He Y; Liu Z; Li N Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636 [TBL] [Abstract][Full Text] [Related]
18. Comparison of EuroQol-5D-3L and Short Form-6D Utility Scores in Family Caregivers of Colorectal Cancer Patients: A Cross-Sectional Survey in China. Sun CY; Liu Y; Zhou LR; Wang MS; Zhao XM; Huang WD; Liu GX; Zhang X Front Public Health; 2021; 9():742332. PubMed ID: 34660519 [No Abstract] [Full Text] [Related]
19. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting. Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067 [TBL] [Abstract][Full Text] [Related]
20. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Kim SH; Kim HJ; Lee SI; Jo MW Qual Life Res; 2012 Aug; 21(6):1065-73. PubMed ID: 21947656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]